Evidence map›Paper›PMID 32901418›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2021

Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.

Talal Asif, Javier Gomez, Vasvi Singh, Rami Doukky, Arlet Nedeltcheva, Saurabh Malhotra

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Cardiac Amyloidosis: Tribulations and New Frontiers.Journal of personalized medicine · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Evolution of cardiac amyloidosis imaging with bone-avid tracers: From qualification to quantification.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2024
    Article
  10. Appraisal of amyloidosis imaging practices in the Middle East/North Africa (PYP-MENA).European heart journal. Imaging methods and practice · 2024
    Article
  11. Article
  12. A Quantitative Diagnostic Method UsingAnnals of nuclear cardiology · 2024
    Article
  13. Lateral Planar Imaging ofAnnals of nuclear cardiology · 2024
    Article
  14. Review
  15. Article
  16. Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  17. Article
  18. ASNC SPECT-MPI quality metrics: a race to the top.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  19. Echocardiographic indices of left ventricular function and filling pressure are not related to blood pool activity on pyrophosphate scintigraphy.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  20. Multimodality imaging for diagnosis of subclinical hereditary transthyretin cardiac amyloidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Talal AsifDivision of Cardiology, Cook County Health, Chicago, USA.
Javier GomezDivision of Cardiology, Cook County Health, Chicago, USA.
Vasvi SinghDivision of Cardiovascular Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, USA.
Rami DoukkyDivision of Cardiology, Cook County Health, Chicago, USA.
Arlet NedeltchevaDivision of Cardiology, Cook County Health, Chicago, USA.
Saurabh MalhotraDivision of Cardiology, Cook County Health, Chicago, USA. saurabh.malhotra@cookcountyhhs.org.
Cook County Health and Hospitals System · USRush University Medical Center · USUniversity at Buffalo, State University of New York · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTc-99m pyrophosphate (PYP) SPECT is recommended for indeterminate findings on planar imaging. We aimed to compare the findings on planar PYP scintigraphy alone to that of routinely performed PYP SPECT.

methodsPYP scintigraphy data of 133 patients (53% men; mean age 76 years) were evaluated. SPECT was routinely performed following 1-hour planar imaging, in all cases. Semiquantitative visual score and heart-to-contralateral (H/CL) ratio were determined in all patients as recommended.

resultsPYP images from 35 patients (26%) were considered to be positive based on SPECT myocardial uptake. Among them, 20 (57%) had a H/CL ratio ≥1.5 and 34 had a visual score ≥ 2. SPECT identified myocardial uptake in one patient with a visual score < 2 and refuted the presence of myocardial uptake in two patients with a visual score ≥ 2. Visual score correlated well with SPECT (r = 0.94; P < .0001) and had an accuracy of 98% for tomographic myocardial uptake. Addition of H/CL ratio reduced the diagnostic performance of visual score.

conclusionsPlanar-derived visual score has an excellent accuracy for tomographic myocardial uptake, though it misclassifies a small proportion of patients. H/CL ratio decreases the diagnostic certainty of planar imaging. Tomographic imaging prevents misdiagnoses and should always be performed.

Indexed as

Radionuclide ImagingRadiopharmaceuticalsTechnetium Tc 99m PyrophosphateTomography, Emission-Computed, Single-PhotonAgedAged, 80 and overAmyloid Neuropathies, FamilialCardiomyopathiesFemaleHumansMaleMiddle AgedPredictive Value of TestsRetrospective StudiesRadiopharmaceuticalsTechnetium Tc 99m PyrophosphateAmyloid heart diseaseImage analysisSPECT

Identifiers

PMID32901418
OpenAlexW3084129529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.